Síntese e caracterização de complexos de Ag(I) e Au(I) contendo ligantes carbenos N-heterocíclicos, potenciais agentes anticâncer e o estudo de seus possíveis mecanismos de ação
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Cancer is one of the major public health challenges worldwide, leading to a significant
demand for more effective and less toxic medications. Rational strategies and approaches are
employed to optimize the design and synthesis of potential new drugs. Knowing the anticancer
activity of well-known antifungal agents like Clotrimazole (CTZ) and Ketoconazole (KTZ), the
study aimed to investigate whether the coordination type would influence the biological activity
of different metal complexes containing these azoles and their N-heterocyclic carbene (NHC)
derivatives as ligands. To address this, two imidazolic salts, L1 [(CTZ-Me)I] and L2 [(KTZMe)I], were synthesized and characterized by reactions between the azole of interest and
iodomethane. Additionally, the synthesis and characterization of all ligands with silver(I)
Ag(L1)(I)].H2O (1), [Ag(L1)2]I.4CH2Cl2 (2), [Ag(CTZ)2]NO3 (3), [Ag(L2)(I)] (4),
[Ag(L2)2]I.2CH2Cl2 (5), and [Ag(KTZ)2]NO3 (6), as well as gold(I) [Au(L1)(Cl)].2CH2Cl2 (7),
[Au(CTZ)(Cl)] (8), [Au(L2)(Cl)] (9), and [Au(KTZ)(Cl)] (10) complexes, were carried out. All
metal complexes and their original ligands were characterized, when possible, using infrared
(IR) and ultraviolet-visible (UV-Vis) spectroscopies, electrospray ionization mass spectrometry
(ESI-MS), nuclear magnetic resonance (1H and 13C NMR), and elemental analysis of carbon,
hydrogen, and nitrogen (CHN). Their structures were proposed based on the analysis of all data,
and, in the case of metal complex 7, through the elucidation of the crystallographic structure of
its crystals. Cytotoxicity studies demonstrated the effects of these compounds on different
tumor and non-tumor cells. Results revealed that the silver(I) complex derived from ligand L1
(1) exhibited ten times greater cytotoxicity than its original ligand against human metastatic
breast adenocarcinoma cells, a highly aggressive lineage. It was also at least fifteen times more
active against murine breast carcinoma cells (4TI). The gold(I) complex (7) showed six times
more cytotoxicity than its original ligand against MDA-MB-231 cells. Silver(I) complexes were
more active than free ligands, with complexes 4 and 5 being the most selective for the B16-F1
cancer cell lineage. These results strongly suggest that the coordination of the ligand to the
metal ion may have influenced the biological activity of the compounds in the studied lineages.
Furthermore, the interaction of the synthesized metal complexes with DNA, bovine serum
albumin (BSA) (only for silver(I) complexes), and glutathione (GSH) (only for gold(I)
complexes) was evaluated. DNA interaction studies using techniques such as
spectrophotometric titration, viscosity, and electrophoresis (for silver(I) compounds) indicated
that DNA is not the target of these compounds, suggesting that cytotoxicity may be related to
another biomolecular target. In interactions with BSA, silver(I) complexes demonstrated
electrostatic interaction, suggesting potential interaction, transport, or retention of these
compounds by the protein. Experiments with GSH and gold(I) complexes (7-10) revealed
strong interaction with glutathione, indicating a rapid reaction of these complexes with this
biomolecule, potentially affecting its stability in the cell. The notable interaction with
glutathione also suggests high reactivity with other enzymes, such as TrxR, which also contains
cysteines in its structure.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

